CD33 and acute myeloid leukemia: Nevertheless, blasts from patients with FLT3-mutated (FLT3mut) AML express high levels of CD33,5 and subgroup analyses from randomized studies suggest that patients with FLT3mut AML benefited from the addition of GO to induction chemotherapy.6